Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Nat Rev Drug Discov. 2022 Nov;21(11):793–794. doi: 10.1038/d41573-021-00190-9

Table 1.

Regulatory factor impact

Regulatory factor Effect (years) 95% CI
Accelerated approval −3.0 (−4.5, −1.5)
Breakthrough designation −1.3 (−2.6, 0.0)
Orphan designation +1.5 (+0.4, +2.6)
>1 Review cycle +1.8 (+0.4, +3.2)

Effect size of US FDA regulatory factors on shortening (−) or increasing (+) clinical development times.

See Supplementary Box 1 for details of the dataset and analysis.